Factors that make an infectious disease outbreak controllable - PubMed (original) (raw)
Factors that make an infectious disease outbreak controllable
Christophe Fraser et al. Proc Natl Acad Sci U S A. 2004.
Abstract
The aim of this study is to identify general properties of emerging infectious agents that determine the likely success of two simple public health measures in controlling outbreaks, namely (i) isolating symptomatic individuals and (ii) tracing and quarantining their contacts. Because these measures depend on the recognition of specific disease symptoms, we investigate the relative timing of infectiousness and the appearance of symptoms by using a mathematical model. We show that the success of these control measures is determined as much by the proportion of transmission occurring prior to the onset of overt clinical symptoms (or via asymptomatic infection) as the inherent transmissibility of the etiological agent (measured by the reproductive number R(0)). From published studies, we estimate these quantities for two moderately transmissible viruses, severe acute respiratory syndrome coronavirus and HIV, and for two highly transmissible viruses, smallpox and pandemic influenza. We conclude that severe acute respiratory syndrome and smallpox are easier to control using these simple public health measures. Direct estimation of the proportion of asymptomatic and presymptomatic infections is achievable by contact tracing and should be a priority during an outbreak of a novel infectious agent.
Figures
Fig. 1.
Key epidemiological determinants. These determinants describe the pattern of typical disease progression for an individual patient as a function of time since infection (measured in arbitrary units). Filled curves represent infectiousness through time (left axis). The black curve represents S(τ), the probability of a person not having developed symptoms by a certain time (right axis). The basic reproduction number _R_0 is the area under the infectiousness curve (solid color plus cross-hatched section). The solid-colored area represents transmission arising prior to symptoms such that θ, the proportion of presymptomatic transmission, is the proportion of the total area under the infectiousness curve that is solid-colored. (A and B) Low- and high-variance incubation and infectiousness distributions, respectively. Both cases have _R_0 = 5, _T_g = 3 (in arbitrary time units), andθ = 0.5; A shows a low variance of 0.1 × mean2, whereas B shows a high variance of 0.5 × mean2.
Fig. 2.
Parameter estimates. Plausible ranges for the key parameters _R_0 and θ (see main text for sources) for four viral infections of public concern are shown as shaded regions. The size of the shaded area reflects the uncertainties in the parameter estimates. The areas are color-coded to match the assumed variance values for β(τ) and S(τ) of Fig. 1 appropriate for each disease, for reasons that are apparent in Fig. 3.
Fig. 3.
Criteria for outbreak control. Each curve represents a different scenario, consisting of a combination of interventions and a choice of parameters. For each scenario, if a given infectious agent is below the _R_0–θ curve, the outbreak is always controlled eventually. Above the curve, additional control measures (e.g., movement restrictions) would be required to control spread. Black lines correspond to isolating symptomatic individuals only. Colored lines correspond to the addition of immediate tracing and quarantining of all contacts of isolated symptomatic individuals. The black (isolation only) line is independent of distributional assumptions made (low or high variance), whereas the colored (isolation + contact tracing) lines match the variance assumptions made in Fig. 1 (red = high variance; blue = low variance). The efficacy of isolation of symptomatic individuals is 100% in A, 90% in B, and 75% in C. Contact tracing and isolation is always assumed 100% effective in the scenarios in which it is implemented (colored lines). Curves are calculated by using a mathematical model of outbreak spread incorporating quarantining and contact tracing (see main text).
Similar articles
- Comparing nonpharmaceutical interventions for containing emerging epidemics.
Peak CM, Childs LM, Grad YH, Buckee CO. Peak CM, et al. Proc Natl Acad Sci U S A. 2017 Apr 11;114(15):4023-4028. doi: 10.1073/pnas.1616438114. Epub 2017 Mar 28. Proc Natl Acad Sci U S A. 2017. PMID: 28351976 Free PMC article. - The effectiveness of contact tracing in emerging epidemics.
Klinkenberg D, Fraser C, Heesterbeek H. Klinkenberg D, et al. PLoS One. 2006 Dec 20;1(1):e12. doi: 10.1371/journal.pone.0000012. PLoS One. 2006. PMID: 17183638 Free PMC article. - Prevention and control of emerging infections: a challenge for the 3rd millennium.
Rezza G. Rezza G. New Microbiol. 2007 Jul;30(3):358-61. New Microbiol. 2007. PMID: 17802926 Review. - Emerging Respiratory Viruses in Children.
Schuster JE, Williams JV. Schuster JE, et al. Infect Dis Clin North Am. 2018 Mar;32(1):65-74. doi: 10.1016/j.idc.2017.10.001. Infect Dis Clin North Am. 2018. PMID: 29406977 Free PMC article. Review.
Cited by
- A Regional-Scale Assessment-Based SARS-CoV-2 Variants Control Modeling with Implications for Infection Risk Characterization.
Yang YF, Lin YJ, You SH, Lu TH, Chen CY, Wang WM, Ling MP, Chen SC, Liao CM. Yang YF, et al. Infect Drug Resist. 2024 Oct 31;17:4791-4805. doi: 10.2147/IDR.S480086. eCollection 2024. Infect Drug Resist. 2024. PMID: 39498414 Free PMC article. - Best practices for estimating and reporting epidemiological delay distributions of infectious diseases.
Charniga K, Park SW, Akhmetzhanov AR, Cori A, Dushoff J, Funk S, Gostic KM, Linton NM, Lison A, Overton CE, Pulliam JRC, Ward T, Cauchemez S, Abbott S. Charniga K, et al. PLoS Comput Biol. 2024 Oct 28;20(10):e1012520. doi: 10.1371/journal.pcbi.1012520. eCollection 2024 Oct. PLoS Comput Biol. 2024. PMID: 39466727 Free PMC article. - A conceptual health state diagram for modelling the transmission of a (re)emerging infectious respiratory disease in a human population.
Avramov M, Gabriele-Rivet V, Milwid RM, Ng V, Ogden NH, Hongoh V. Avramov M, et al. BMC Infect Dis. 2024 Oct 24;24(1):1198. doi: 10.1186/s12879-024-10017-8. BMC Infect Dis. 2024. PMID: 39448915 Free PMC article. - Exploring pathogen population density as a metric for understanding post-COVID infectious disease surges.
Zhang L. Zhang L. Front Immunol. 2024 Oct 3;15:1459628. doi: 10.3389/fimmu.2024.1459628. eCollection 2024. Front Immunol. 2024. PMID: 39421748 Free PMC article. - The optimal spatially-dependent control measures to effectively and economically eliminate emerging infectious diseases.
Xia F, Xiao Y, Ma J. Xia F, et al. PLoS Comput Biol. 2024 Oct 7;20(10):e1012498. doi: 10.1371/journal.pcbi.1012498. eCollection 2024 Oct. PLoS Comput Biol. 2024. PMID: 39374303 Free PMC article.
References
- Riley, S., Fraser, C., Donnelly, C. A., Ghani, A. C., Abu-Raddad, L. J., Hedley, A. J., Leung, G. M., Ho, L. M., Lam, T. H., Thach, T. Q., et al. (2003) Science 300, 1961-1966. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources